Nashoba Biotechnology
Advertisement
Nashoba Biotechnology, based in Acton, MA, is focused on reprogramming the tumor microenvironment to develop a new class of anticancer drugs. The company is dedicated to enhancing the efficacy of existing immunotherapies, particularly immune checkpoint inhibitors, by targeting specific glycan structures within the tumor microenvironment.
With a mission to improve patient outcomes, Nashoba Biotechnology aims to provide innovative first-in-class medicines that work synergistically with other therapeutic agents to increase overall survival rates across various cancer types. Their research highlights the critical role of non-cancerous components in tumors and seeks to alter molecular conversations that drive cancer progression.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.
Advertisement
